Literature DB >> 9776448

Differentiated thyroid cancer in children and adolescents.

J Farahati1, T Parlowsky, U Mäder, C Reiners, P Bucsky.   

Abstract

INTRODUCTION: There have been only a few studies on differentiated childhood thyroid cancer (DTC) in children and adolescents.
METHODS: We analyzed the characteristics of DTC with respect to age, gender and histology in 114 patients under 18 years of age. In a questionnaire-based survey, data of 114 patients, aged between 3 years and 18 years, was collected from 65 clinical institutions in Germany. Characteristics of 80 females and 34 males were evaluated, and the prognostic effect of age, gender, histology, multicentric growth, tumor stage and N-status on distant metastases was tested using multivariate discriminant analysis. Between-group comparison was performed using student t-test and chi-squared test.
RESULTS: The incidence of DTC in females was higher than in males with a peak of female:male ratio at puberty, which was more pronounced in children with papillary thyroid cancer, but not with follicular thyroid cancer. Papillary thyroid cancer was associated with more advanced disease (P=0.009), more lymph-node involvement (P=0.007) and more distant metastases (P=0.02) compared with follicular thyroid cancer. Multivariate analysis showed advanced tumor stage as the only significant factor (P=0.02) associating with distant metastasis.
CONCLUSION: It can be concluded that in children and adolescents: 1. The incidence of papillary thyroid cancer is higher in females than males, with a peak at puberty. 2. The only significant factor associated with distant metastases is the advanced tumor stage. 3. Childhood thyroid cancer is frequently associated with lymph-node involvement, distant metastases and advanced tumor stage. 4. Papillary childhood thyroid cancer is more aggressive than follicular type.

Entities:  

Mesh:

Year:  1998        PMID: 9776448     DOI: 10.1007/s004230050124

Source DB:  PubMed          Journal:  Langenbecks Arch Surg        ISSN: 1435-2443            Impact factor:   3.445


  7 in total

1.  Predictive factors for recurrence of differentiated thyroid cancer in patients under 21 years of age and a meta-analysis of the current literature.

Authors:  Ning Qu; Ling Zhang; Zhong-Wu Lu; Qing-Hai Ji; Shu-Wen Yang; Wen-Jun Wei; Yan Zhang
Journal:  Tumour Biol       Date:  2015-12-22

2.  Pediatric thyroid cancers: an Indian perspective.

Authors:  Devendra A Chaukar; Abhishek D Vaidya
Journal:  Indian J Surg Oncol       Date:  2012-02-16

Review 3.  The treatment of differentiated thyroid cancer in children: emphasis on surgical approach and radioactive iodine therapy.

Authors:  Scott A Rivkees; Ernest L Mazzaferri; Frederik A Verburg; Christoph Reiners; Markus Luster; Christopher K Breuer; Catherine A Dinauer; Robert Udelsman
Journal:  Endocr Rev       Date:  2011-08-31       Impact factor: 19.871

4.  Comprehensive clinical assessment of 740 cases of surgically treated thyroid cancer in children of Belarus.

Authors:  Yuri E Demidchik; Eugene P Demidchik; Christoph Reiners; Johannes Biko; Mariko Mine; Vladimir A Saenko; Shunichi Yamashita
Journal:  Ann Surg       Date:  2006-04       Impact factor: 12.969

5.  Paediatric differentiated thyroid carcinoma: a UK National Clinical Practice Consensus Guideline.

Authors:  Sasha R Howard; Sarah Freeston; Barney Harrison; Louise Izatt; Sonali Natu; Kate Newbold; Sabine Pomplun; Helen A Spoudeas; Sophie Wilne; Tom R Kurzawinski; Mark N Gaze
Journal:  Endocr Relat Cancer       Date:  2022-09-07       Impact factor: 5.900

Review 6.  Imaging 'the lost tribe': a review of adolescent cancer imaging. Part 1.

Authors:  P D Humphries; I Zerizer
Journal:  Cancer Imaging       Date:  2009-11-06       Impact factor: 3.909

7.  Birth Characteristics and Risk of Pediatric Thyroid Cancer: A Population-Based Record-Linkage Study in California.

Authors:  Nicole C Deziel; Yawei Zhang; Rong Wang; Joseph L Wiemels; Libby Morimoto; Cassandra J Clark; Catherine Metayer; Xiaomei Ma
Journal:  Thyroid       Date:  2020-10-07       Impact factor: 6.568

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.